首页> 外文期刊>BJU international >Long-term results of permanent urethral stent Memotherm implantation in the management of recurrent bulbar urethral stenosis.
【24h】

Long-term results of permanent urethral stent Memotherm implantation in the management of recurrent bulbar urethral stenosis.

机译:永久性尿道内支架置入术治疗复发性延髓性尿道狭窄的长期结果。

获取原文
获取原文并翻译 | 示例
           

摘要

What's known on the subject? and What does the study add? Milroy reported 84% success at a mean of 4.5 years follow-up by usage of a permanently implantable urolume use. Our study is one of the largest in this urea, with a high number of patients and a long follow-up period. OBJECTIVE: * To evaluate the effectiveness and long-term results of permanent urethral stent (Memotherm) implantation in the treatment of recurrent bulbar urethral stricture. PATIENTS AND METHODS: * In all, 47 patients with a history of previous unsuccessful treatment for bulbar urethral stricture were treated using Memotherm bulbar urethral stents between 1998 and 2002. * Long-term follow-up data was analysed and discussed. RESULTS: * At the end of the 7-year period 37 of 47 patients (78.7%) had been treated successfully. * Post-micturition dribbling incontinence lasting up to 3 months after stent placement occurred in 32 (68.1%) patients, but this was reduced to only seven patients (14.9%) by the 7-year follow-up. * There was stress incontinence of various severities in nine (19.2%) patients at the 1-year follow-up. These patients were those who had stenosed urethral segments adjacent to the external sphincter. At the long-term follow-up <10% of the patients had stress incontinence complaints. CONCLUSION: * Memotherm is a good treatment option in patients with recurrent bulbar urethral stricture of any cause.
机译:关于这个主题有什么了解?该研究增加了什么? Milroy报告说,通过使用永久植入的尿管,平均随访4.5年成功率达到84%。我们的研究是尿素中最大的研究之一,患者人数众多且随访时间长。目的:*评估永久性尿道支架植入术(Memotherm)在复发性延髓性尿道狭窄治疗中的效果和长期效果。患者与方法:*在1998年至2002年之间,使用Memotherm球根尿道支架治疗了47例先前未曾成功治疗球根尿道狭窄的患者。*分析并讨论了长期随访数据。结果:*在7年末,成功治疗了47例患者中的37例(78.7%)。 *排尿后尿失禁持续至支架置入后3个月,持续发生32例(68.1%),但经过7年的随访,仅减少到7例(14.9%)。 *在1年的随访中,有9名(19.2%)的患者出现了各种严重程度的压力性尿失禁。这些患者是在外部括约肌附近狭窄了尿道段的患者。在长期随访中,<10%的患者有压力性尿失禁主诉。结论:*对于任何原因复发性延髓性尿道狭窄患者,放疗是一种很好的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号